![Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German) Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/55445/55445fig1.jpg)
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)
![DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents](https://patentimages.storage.googleapis.com/0b/ee/ef/27e04b09a0ac32/00380001.png)
DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents
![DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents](https://patentimages.storage.googleapis.com/6e/41/f2/4d00e6ae4a3879/00390001.png)
DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents
![DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents](https://patentimages.storage.googleapis.com/c0/f7/de/e06b0be134cec3/00370001.png)
DE60004635T2 - BAFF, THEIR INHIBITORS AND THEIR USE FOR MODULATING THE B CELL REPLY - Google Patents
![EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents](https://patentimages.storage.googleapis.com/7d/34/d2/42f77fd0c0785b/00240001.png)
EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents
![Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German) Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/55445/55445fig2.jpg)
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)
![Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German) Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/10494/10494fig2.jpg)
Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German)
![Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods | Protocol (Translated to German) Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/60335/60335fig04.jpg)